Pneumotox. ne fonctionne plus

However, double-checking is recommended. cette application is a repository built from over 35,000 published bibliographic references (mainly indexed in PubMed) individually reviewed and rearranged by causative drugs (n>1,500) including chemicals and substances of abuse, be they administered buccally, parenterally, topically or via inhalation (e. g. e-cigarettes, vaping, inhalants, gases), and by patterns of respiratory involvement (n>650).  If a drug reaction is listed in cette application, this does not equate diagnosis in the patient.  You may access cette application by drug names (International Nonproprietary Names or INN, alphabetical) or patterns grouped by families.  cette application is an aid to the investigation and diagnosis of respiratory and cardiac diseases/reactions suspected of being drug-induced/iatrogenic.  If needed, ask your treating Doctor. cette application is designed to provide information and bibliography more quickly and extensively than a manual search on conventional databases may do.  There may be unpublished reports, or you may be seeing the first case, or we may have missed some information. cette application cannot be held responsible in such situations.  Conversely, lack of description in the literature or in cette application does not rule out the diagnosis.  In any patient, particularly when severe respiratory failure, ARDS or acute asthma is present, survey of exposure to drugs, substances, and/or chemicals must be done carefully with patient, family, health professionals, and/or pharmacy. This can be life-saving.  Please rate the likelihood for drug causality in every case, using the ‘Diagnosing DIRD’ prompt/button and the Naranjo scale to decide whether to withdraw or prudently continue the drug.  You may contact cette application 24/7 through the contact window. cette application V2.  Where in doubt, consider double-checking PubMed, your affiliated Safety for Medicines Department/Agency and the Pharmacovigilance Department of drug companies.  Please examine what INN are exactly contained in any suspected proprietary drug, including excipients.  Early sampling of body fluids for drug and metabolites is indicated when appropriate shortly upon admission, particularly in the severely ill.  Ultimately, exact diagnosis and causality assessment remain full users’ responsibility.  They may host more/undisclosed useful information compared to literature.  Patients should be reassured and realize that such incidents are rare.